- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/14 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 263/14
Total number of patents in this class: 71
10-year publication summary
|
2
|
4
|
3
|
6
|
3
|
4
|
4
|
2
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sumitomo Chemical Company, Limited | 9018 |
3 |
| Epitech Group S.r.l. | 22 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 868 |
3 |
| Toyama Chemical Co., Ltd. | 103 |
3 |
| Oncternal Therapeutics, Inc. | 46 |
3 |
| Amgen Inc. | 4055 |
2 |
| FUJIFILM Corporation | 29251 |
2 |
| Nankai University | 233 |
2 |
| Sirna Therapeutics, Inc. | 111 |
2 |
| Sun Chemical B.V. | 359 |
2 |
| Transitions Optical, Inc. | 257 |
2 |
| Zhejiang University of Technology | 243 |
2 |
| Celltaxis, LLC | 26 |
2 |
| L'OREAL, Société Anonyme | 15364 |
1 |
| The Regents of the University of California | 19839 |
1 |
| AstraZeneca AB | 2933 |
1 |
| Mars, Incorporated | 2932 |
1 |
| Massachusetts Institute of Technology | 10019 |
1 |
| BioLab Ltd. | 5 |
1 |
| Cadila Healthcare Limited | 321 |
1 |
| Other owners | 33 |